5th Mar 2013 10:55
Notice of Results
LONDON, UK, 05 March, 2013 - Skyepharma PLC (LSE: SKP) will announce its preliminary results for the year ended 31 December 2012, on Thursday 21 March 2013. A recording of the event will be available on the Company's website at www.skyepharma.com.
For further information please contact:
Skyepharma PLC | |
Peter Grant, Chief Executive Officer | +44 207 881 0524 |
| |
FTI Consulting | |
Julia Phillips/Susan Stuart/Natalie Garland-Collins | +44 207 831 3113 |
About Skyepharma PLC
Skyepharma uses its multiple drug delivery technologies and expertise to create pharmaceutical products. The Group receives revenues from 13 approved products in the areas of inhalation, oral, topical and injectable delivery as well as generating income from the development of further products and technology licenses. The Group's products are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com.
Related Shares:
SKP.L